Works matching IS 0278-0232 AND VI 42 AND IP 5 AND DT 2024

Results: 14

Direct determination of chronic myeloid leukemia prevalence in Lombardy—Italy: Global implications.
Published in:
Hematological Oncology, 2024, v. 42, n. 5, p. 1, doi. 10.1002/hon.3311
By:
- Polverelli, N.;
- Anghilieri, M.;
- Elena, C.;
- Intermesoli, T.;
- Pungolino, E.;
- D'Adda, M.;
- Iurlo, A.;
- Maffioli, M.;
- Lunghi, F.;
- Bertolli, V.;
- Orofino, N.;
- Sissa, C.;
- Fiamenghi, C.;
- Gardellini, A.;
- Ubezio, M.;
- Carraro, M. C.;
- Corradini, P.;
- Giglio, F.;
- Pasquini, M. C.;
- Palazzolo, R.
Publication type:
Article
Secondary acute myeloid leukemia and early infection are independent predictors of poor survival in acute myeloid leukemia treated with hypomethylating agents and venetoclax.
Published in:
Hematological Oncology, 2024, v. 42, n. 5, p. 1, doi. 10.1002/hon.3310
By:
- Cordella, Stefano;
- Giusti, Davide;
- De Bellis, Eleonora;
- Dargenio, Michelina;
- Creti', Federica;
- Lazzarotto, Davide;
- Cattaneo, Chiara;
- Fracchiolla, Nicola Stefano;
- Piccini, Matteo;
- Forghieri, Fabio;
- Pagano, Livio;
- Candoni, Anna
Publication type:
Article
Treatment‐free remission as a new goal in the management of chronic myeloid leukemia: Clinical and biological aspects.
Published in:
Hematological Oncology, 2024, v. 42, n. 5, p. 1, doi. 10.1002/hon.3309
By:
- Cattaneo, Daniele;
- Bucelli, Cristina;
- Bellani, Valentina;
- Mora, Barbara;
- Iurlo, Alessandra
Publication type:
Article
Bruton tyrosine kinase inhibitor monotherapy in B‐cell lymphoma and risk of infection: A systematic review and meta‐analysis of randomized controlled trials.
Published in:
Hematological Oncology, 2024, v. 42, n. 5, p. 1, doi. 10.1002/hon.3308
By:
- Zuber, Mohammed;
- Borate, Samruddhi Nandkumar;
- Gokhale, Pooja;
- Yerubandi, Akhila;
- Alam Bhuiya, N. M. Mahmudul;
- Rawal, Smita;
- Young, Henry N.;
- Villa Zapata, Lorenzo
Publication type:
Article
Research on the mechanism of HOPX‐HDAC2 interaction inducing differentiation blockage in acute myeloid leukemia.
Published in:
Hematological Oncology, 2024, v. 42, n. 5, p. 1, doi. 10.1002/hon.3307
By:
- He, Fang;
- Tu, Yan;
- Ni, Lihong
Publication type:
Article
Adverse impact of 1q amplification on outcomes in patients with multiple myeloma treated with daratumumab, carfilzomib and dexamethasone in a real‐world clinical setting.
Published in:
Hematological Oncology, 2024, v. 42, n. 5, p. 1, doi. 10.1002/hon.3306
By:
- Kikuchi, Taku;
- Tsukada, Nobuhiro;
- Kunisada, Kodai;
- Matsumoto, Chiaki;
- Nomura‐Yogo, Moe;
- Oda, Yuki;
- Sato, Kota;
- Takei, Tomomi;
- Ogura, Mizuki;
- Abe, Yu;
- Suzuki, Kenshi;
- Hosoya, Osamu;
- Ishida, Tadao
Publication type:
Article
Combined targeting of Hedgehog/GLI1 and Wnt/β‐catenin pathways in mantle cell lymphoma.
Published in:
Hematological Oncology, 2024, v. 42, n. 5, p. 1, doi. 10.1002/hon.3305
By:
- Han, Yan;
- Li, Chuntuan;
- Liu, Shengquan;
- Gao, Jingjing;
- He, Yanjun;
- Xiao, Huifang;
- Chen, Qi;
- Zheng, Yan;
- Chen, Hongyuan;
- Zhu, Xiongpeng
Publication type:
Article
From trials to statistical insights: Bortezomib's story in childhood T‐cell lymphoid malignancies.
Published in:
Hematological Oncology, 2024, v. 42, n. 5, p. 1, doi. 10.1002/hon.3304
By:
- Srinivasan, Shyam
Publication type:
Article
Clinical characteristics and outcome of early‐stage diffuse large B cell lymphoma of female genital track: A retrospective study of the Hellenic cooperative lymphoma group.
Published in:
Hematological Oncology, 2024, v. 42, n. 5, p. 1, doi. 10.1002/hon.3303
By:
- Verrou, Evgenia;
- Papageorgiou, Sotirios G.;
- Bouzani, Maria;
- Sevastoudi, Aggeliki;
- Triantafyllou, Theodora;
- Daiou, Aikaterini;
- Dalampira, Dimitra;
- Arapaki, Maria;
- Giatra, Chara;
- Banti, Anastasia;
- Kyriakidis, Gerasimos;
- Stoumpos, Dionisios;
- Karampatzakis, Nikolaos;
- Papadopoulou, Theodosia;
- Kotsopoulou, Maria;
- Pouli, Anastasia;
- Mandala, Evdokia;
- Pappa, Vassiliki;
- Spanoudakis, Emmanouil;
- Katodritou, Eirini
Publication type:
Article
Prognostic value of the "dynamic" R2‐ISS in patients with multiple myeloma undergoing anti‐CD38 antibody‐based triplet therapies.
Published in:
Hematological Oncology, 2024, v. 42, n. 5, p. 1, doi. 10.1002/hon.3302
By:
- Kikuchi, Taku;
- Oda, Yuki;
- Kondo, Ukyo;
- Tsukada, Nobuhiro;
- Kunisada, Kodai;
- Matsumoto, Chiaki;
- Nomura‐Yogo, Moe;
- Sato, Kota;
- Takei, Tomomi;
- Ogura, Mizuki;
- Abe, Yu;
- Suzuki, Kenshi;
- Hosoya, Osamu;
- Ishida, Tadao
Publication type:
Article
Role of gut microbiome in the outcome of lymphoma patients treated with checkpoint inhibitors—The MicroLinf Study.
Published in:
Hematological Oncology, 2024, v. 42, n. 5, p. 1, doi. 10.1002/hon.3301
By:
- Casadei, Beatrice;
- Conti, Gabriele;
- Barone, Monica;
- Turroni, Silvia;
- Guadagnuolo, Serafina;
- Broccoli, Alessandro;
- Brigidi, Patrizia;
- Argnani, Lisa;
- Zinzani, Pier Luigi
Publication type:
Article
Characteristics, outcomes and health care utilization of patients with acute myeloid leukemia aged 70 years or older: A single‐center retrospective analysis.
Published in:
Hematological Oncology, 2024, v. 42, n. 5, p. 1, doi. 10.1002/hon.3300
By:
- Neumann, Marie Anne‐Catherine;
- Naendrup, Jan‐Hendrik;
- Garcia Borrega, Jorge;
- Halmer, Ismini;
- Altenrath, Lisa;
- Sieg, Noelle;
- Hallek, Michael;
- Eichenauer, Dennis A.;
- Heger, Jan‐Michel
Publication type:
Article
Efficacy of escalating therapy with brentuximab vedotin‐AVD in advanced stage Hodgkin lymphoma patients with positive interim positron emission tomography after ABVD.
Published in:
Hematological Oncology, 2024, v. 42, n. 5, p. 1, doi. 10.1002/hon.3299
By:
- Martínez, Carmen;
- Carcelero, Esther;
- Gutiérrez, Antonio;
- Sancho, Esther;
- Martí‐Tutusaus, Josep Maria;
- Magnano, Laura;
- Mozas, Pablo;
- Fernández‐Avilés, Francesc;
- Antelo, María Gabriela;
- Setoain, Xavier;
- Rodríguez, Sonia;
- Esteve, Jordi
Publication type:
Article
Issue Information.
Published in:
Hematological Oncology, 2024, v. 42, n. 5, p. 1, doi. 10.1002/hon.3181
Publication type:
Article